Latest North America News

Anson Resources and POSCO Holdings have advanced their collaboration on the Green River Direct Lithium Extraction demonstration plant, with POSCO’s investment decision timeline pushed to early 2026. The partnership signals a strategic move to secure North American lithium resources and commercialize cutting-edge extraction technology.

4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.

Medallion Metals has raised $60 million through a placement and share purchase plan to advance its integrated gold-copper development strategy, targeting first production in early 2027.

Blue Star Helium has completed mechanical assembly of its Galactica helium facility and is set to begin commissioning this week, aiming for first production by December 2025.

DigiCo Infrastructure REIT has announced a 6.0 cents per security distribution for the half-year ending December 2025, reflecting steady income from its expanding data centre portfolio.

Canadian Phosphate Limited has raised A$2 million to advance its sedimentary phosphate projects in Canada, targeting fertilizer and battery material markets with new drilling and technology partnerships.

SenSen Networks reports robust Q2 FY26 revenue momentum, driven by five new city wins in North America, a surge in variable licence fees in Australia, and expanded fuel retail site deployments.

4DMedical secures a key clinical adoption milestone as the University of Miami begins using its CT – VQ™ respiratory imaging technology, following Stanford’s lead. Meanwhile, Lahey Hospital inks a two-year deal for IQ-UIP™, underscoring growing traction in US academic medical centers.

Pinnacle Minerals has restarted exploration at its strategically located Adina East Lithium Project in Quebec’s James Bay region, aiming to capitalize on a booming lithium corridor amid rising market prices.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

Eden Innovations has landed its largest order yet from Holcim Ecuador, signalling accelerating demand for its EdenCrete®Pz7 concrete additive and reinforcing its growth trajectory.

Ainsworth Game Technology forecasts a slight decline in full-year profit driven by weaker North American sales in the second half, despite revenue growth in Asia-Pacific and Latin America.